Details
| Stereochemistry | MIXED |
| Molecular Formula | C15H12N2O2 |
| Molecular Weight | 252.268 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)N1C2=C(C=CC=C2)C3OC3C4=C1C=CC=C4
InChI
InChIKey=ZRWWEEVEIOGMMT-UHFFFAOYSA-N
InChI=1S/C15H12N2O2/c16-15(18)17-11-7-3-1-5-9(11)13-14(19-13)10-6-2-4-8-12(10)17/h1-8,13-14H,(H2,16,18)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation. | 2001 Feb |
|
| Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation. | 2002 May-Aug |
|
| Elevation of carbamazepine-10,11-epoxide by quetiapine. | 2002 Nov |
|
| Administration of Carbatrol to children with feeding tubes. | 2002 Sep |
|
| In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. | 2003 Jun |
|
| Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations. | 2005 Jul |
|
| Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects. | 2005 Jun |
|
| Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. | 2005 Mar |
|
| Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. | 2006 Nov |
|
| Approaches to treatment of type 2 diabetes. | 2008 Aug |
|
| Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions. | 2009 Jun |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
36507-30-9
Created by
admin on Sat Dec 16 08:12:20 GMT 2023 , Edited by admin on Sat Dec 16 08:12:20 GMT 2023
|
PRIMARY | |||
|
DTXSID60891456
Created by
admin on Sat Dec 16 08:12:20 GMT 2023 , Edited by admin on Sat Dec 16 08:12:20 GMT 2023
|
PRIMARY | |||
|
3388
Created by
admin on Sat Dec 16 08:12:20 GMT 2023 , Edited by admin on Sat Dec 16 08:12:20 GMT 2023
|
PRIMARY | |||
|
QC9505F279
Created by
admin on Sat Dec 16 08:12:20 GMT 2023 , Edited by admin on Sat Dec 16 08:12:20 GMT 2023
|
PRIMARY | |||
|
2555
Created by
admin on Sat Dec 16 08:12:20 GMT 2023 , Edited by admin on Sat Dec 16 08:12:20 GMT 2023
|
PRIMARY |
PARENT (METABOLITE ACTIVE)
SUBSTANCE RECORD
